:
Acetyl-l-carnitine concentration increased by 43% after oral supplementation at a dose of 2 g/day, indicating that acetyl-l-carnitine partial absorption without hydrolysis or immediate re-acetylation also occurs [4, 39]
A recent trial in fibromyalgia patients shows this diet might produce significant reductions in pain, fatigue, and sleep disruption
has also received CME-related honoraria or consulting fees from CASEN Recordati, Organon, Lundbeck, and the Academy for Continuing Medical Education (Akademijazakme), with no financial or other conflicts of interest relevant to the subject of this article
10.1016/j.aninu.2021.09.012 45
Answer: Reported tolerability of these peptides is generally favorable in the literature, but they are not FDA-approved drugs, long-term human safety data is limited, and use should always be medically supervised